Følg Karo Pharma

Pressemeldinger Se alle 9 treff

Oppfriskende nyhet fra Weifa: Nazamér Mentol
Invitation to presentation of Weifa's Q4 2016 results

Invitation to presentation of Weifa's Q4 2016 results

Pressemeldinger   •   feb 10, 2017 10:05 CET

Norway's leading consumer health company, will release its fourth quarter and full-year 2016 results on Thursday 16 February 2017.

New license agreement with AFT Pharmaceuticals for Nordic rights to groundbreaking product line within Pain Management

New license agreement with AFT Pharmaceuticals for Nordic rights to groundbreaking product line within Pain Management

Pressemeldinger   •   jan 12, 2017 10:20 CET

Weifa has in-licensed a patented fixed-combination product line within pain management from AFT Pharmaceuticals (“AFT”) in New Zealand. The agreement gives rights to commercialize the products in the entire Nordic region (Norway, Sweden, Denmark, Finland and Iceland).

Invitation to presentation of Weifa's Q3 2016 results, Tuesday 25 October

Invitation to presentation of Weifa's Q3 2016 results, Tuesday 25 October

Pressemeldinger   •   okt 18, 2016 14:10 CEST

Norway's leading consumer health company, will release its third quarter 2016 results on Tuesday 25 October 2016.